Biotech on a Shoestring? There’s a Better Way

A recent Xconomy article “Biotech on a Shoestring” reflects an industry landscape change where, “the era of free-spending is supposedly out, and austerity is the watchword.” An emphasis on a heightened form of frugality can certainly save dollars but can also create uncertainty and anxiety amongst the rank and file. The inevitable next question arises … Continue reading “Biotech on a Shoestring? There’s a Better Way”